Suhail Zahid, Musani Mohammad Ayub, Afaq Salman, Zafar Abbas, Ahmed Ashrafi Syed Khalid
Department of ENT, Karachi Medical and Dental College and Abbasi Shaheed Hospital, Karachi.
J Coll Physicians Surg Pak. 2010 Jan;20(1):55-6.
Follicular dendritic cell sarcoma is a very rare entity. So far only 12 cases have been reported world wide with involvement of tonsil. We present a new case of follicular dendritic cell sarcoma of the tonsil in a 52 years old woman with no evidence of neck node involvement. She had undergone diagnostic tonsillectomy due to unilateral tonsillar enlargement. The final diagnosis after histological review and immunohistochemical stains was follicular dendritic cell sarcoma. Bone scan showed no metastasis. One year follow-up after postoperative chemotherapy showed no evidence of local or regional recurrence. Follicular dendritic cell sarcoma is a rare and underdiagnosed neoplasm. It should be included in the differential diagnosis of any tonsillar mass in adults. Follicular dendritic cell markers such as SR-100, CD21 and/or CD35 are essential for the diagnosis.
滤泡性树突状细胞肉瘤是一种非常罕见的疾病。迄今为止,全球仅报道了12例累及扁桃体的病例。我们报告了一例52岁女性扁桃体滤泡性树突状细胞肉瘤的新病例,该患者无颈部淋巴结受累证据。她因单侧扁桃体肿大接受了诊断性扁桃体切除术。经组织学检查和免疫组化染色后的最终诊断为滤泡性树突状细胞肉瘤。骨扫描显示无转移。术后化疗一年随访显示无局部或区域复发迹象。滤泡性树突状细胞肉瘤是一种罕见且诊断不足的肿瘤。它应被纳入成人任何扁桃体肿物的鉴别诊断中。诸如SR-100、CD21和/或CD35等滤泡性树突状细胞标志物对诊断至关重要。